Abstract
Personalized cancer care holds significant potential for the selection of more effective cancer treatments with major improvements in the quality of life for cancer patients. For instance, the development of new chemotherapeutics with much wider ranges of anti-cancer action is now providing oncologist with broad choices to tailor therapy to specific patients. However, matching therapy to individual patients has remained an obstacle because of reliance on outdated cell culture techniques [1].
© 2014 Optical Society of America
PDF Article | Presentation VideoMore Like This
David D. Nolte, Ran An, Michael Childress, and John Turek
ATh1O.6 CLEO: Applications and Technology (CLEO:A&T) 2014
David D. Nolte, Zhe Li, Honggu Choi, John Turek, and Shadia Jalal
CTu4B.7 Clinical and Translational Biophotonics (Translational) 2018
David Nolte, Dawith Lim, Zhen Hua, and John Turek
HM1C.2 Digital Holography and Three-Dimensional Imaging (DH) 2023